These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6141819)

  • 21. [Psychophysiology and neuroendocrinology of depression].
    Czernik A
    Monogr Gesamtgeb Psychiatr Psychiatry Ser; 1982; 31():1-203. PubMed ID: 6132333
    [No Abstract]   [Full Text] [Related]  

  • 22. [Role of the neurohypophysis in psychological stress].
    Scantamburlo G; Ansseau M; Legros JJ
    Encephale; 2001; 27(3):245-59. PubMed ID: 11488255
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuroendocrine abnormalities in patients with traumatic brain injury.
    Yuan XQ; Wade CE
    Front Neuroendocrinol; 1991; 12(3):209-30. PubMed ID: 11538874
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impaired hypothalamic-pituitary-adrenocortical (HPA) system is related to severity of benzodiazepine withdrawal in patients with depression.
    Wichniak A; Brunner H; Ising M; Pedrosa Gil F; Holsboer F; Friess E
    Psychoneuroendocrinology; 2004 Oct; 29(9):1101-8. PubMed ID: 15219633
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Longitudinal neuroendocrine changes assessed by dexamethasone/CRH and growth hormone releasing hormone tests in psychotic depression.
    Owashi T; Otsubo T; Oshima A; Nakagome K; Higuchi T; Kamijima K
    Psychoneuroendocrinology; 2008 Feb; 33(2):152-61. PubMed ID: 18068306
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differences in the response to the combined DEX-CRH test between PTSD patients with and without co-morbid depressive disorder.
    de Kloet C; Vermetten E; Lentjes E; Geuze E; van Pelt J; Manuel R; Heijnen C; Westenberg H
    Psychoneuroendocrinology; 2008 Apr; 33(3):313-20. PubMed ID: 18215470
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypothalamic-pituitary-adrenal axis activity and age in major depression.
    Nelson WH; Orr WW; Shane SR; Stevenson JM
    J Clin Psychiatry; 1984 Mar; 45(3):120-1. PubMed ID: 6698943
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sex differences in the ACTH response to 24H metyrapone in depression.
    Young EA; Ribeiro SC
    Brain Res; 2006 Dec; 1126(1):148-55. PubMed ID: 16824495
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The dexamethasone suppression test in depression. Critical review].
    Bailly D; Goudemand M; Parquet PJ
    Encephale; 1984; 10(4):155-69. PubMed ID: 6389093
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Defining the boundaries of atypical depression: evidence from the HPA axis supports course of illness distinctions.
    Stewart JW; Quitkin FM; McGrath PJ; Klein DF
    J Affect Disord; 2005 Jun; 86(2-3):161-7. PubMed ID: 15935235
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The stress system in the human brain in depression and neurodegeneration.
    Swaab DF; Bao AM; Lucassen PJ
    Ageing Res Rev; 2005 May; 4(2):141-94. PubMed ID: 15996533
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Biological factors of post-traumatic stress: neuroendocrine aspects].
    Birmes P; Escande M; Gourdy P; Schmitt L
    Encephale; 2000; 26(6):55-61. PubMed ID: 11217539
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Do anxiety and depression have a common pathophysiological mechanism?
    Boyer P
    Acta Psychiatr Scand Suppl; 2000; (406):24-9. PubMed ID: 11131467
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Changes in hormonal indicators during the treatment of depression of different types].
    Krasnov VI; Kokhanenko EM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1989; 89(4):101-5. PubMed ID: 2750367
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The dexamethasone suppression test in patients with postpsychotic depressions.
    Siris SG; Rifkin A; Reardon GT; Doddi SR; Foster P; Strahan A; Morgan V
    Biol Psychiatry; 1984 Sep; 19(9):1351-6. PubMed ID: 6498257
    [No Abstract]   [Full Text] [Related]  

  • 36. Stress responsive neurohormones in depression and anxiety.
    Ströhle A; Holsboer F
    Pharmacopsychiatry; 2003 Nov; 36 Suppl 3():S207-14. PubMed ID: 14677081
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuroendocrine changes in depression.
    Joyce PR
    Aust N Z J Psychiatry; 1985 Jun; 19(2):120-7. PubMed ID: 2413836
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Uncoupling of social zeitgebers and diurnal cortisol secretion in clinical depression.
    Stetler C; Dickerson SS; Miller GE
    Psychoneuroendocrinology; 2004 Nov; 29(10):1250-9. PubMed ID: 15288704
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adrenal gland volume in major depression: relationship to basal and stimulated pituitary-adrenal cortical axis function.
    Rubin RT; Phillips JJ; McCracken JT; Sadow TF
    Biol Psychiatry; 1996 Jul; 40(2):89-97. PubMed ID: 8793041
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Depression, cortisol and somatoform dissociative symptoms.
    Bob P; Freybergh PF; Jasova D; Susta M; Pavlat J; Zima T; Benakova H; Bizik G; Svetlak M; Vevera J; Miklosko J; Hajek K; Raboch J
    Neuro Endocrinol Lett; 2008 Apr; 29(2):235-9. PubMed ID: 18404142
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.